Drug Type Monoclonal antibody |
Synonyms Monoclonal antibody CR6261, CR-6261, JNJ-54235025 + [1] |
Target |
Mechanism hemagglutinin modulators(Influenza virus hemagglutinin glycoproteins modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Diridavumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 2 | US | 25 Feb 2015 | |
Influenza A virus infection | Phase 2 | US | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | AU | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | BE | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | BR | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | BG | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | CA | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | FR | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | DE | 01 Dec 2013 | |
Influenza A virus infection | Phase 2 | NL | 01 Dec 2013 |
Phase 2 | 104 | wxwtklmehv(hjjskmzohg) = caozopvmgb mjbrbpggeu (suirguvkdc ) | Negative | 19 Nov 2020 | |||
Placebo | wxwtklmehv(hjjskmzohg) = luljwxhtpi mjbrbpggeu (suirguvkdc ) | ||||||
Phase 2 | 104 | uduakgcutw(tjolzszivg) = okelvntxqb aoyldqivmf (ygvwbrsmqv, isvryoaomd - xdslnupuwt) View more | - | 17 Feb 2020 |